New technologies and screening strategies for hepatotoxicity: use of in vitro models

…, BA Andrews, F Moulin - Toxicologic pathology, 2005 - journals.sagepub.com
Hepatotoxicity remains a significant cause for drug failures during clinical trials. This is due,
in part, to the idiosyncratic nature of toxicity in humans and inherent physiological …

Prevention of infections during primary immunodeficiency

…, A Jaccard, PH Consigny, F Moulin… - Clinical infectious …, 2014 - academic.oup.com
Preventing infection during primary immunodeficiency (PID) can include antimicrobial
agents, immunotherapy, and immunization, depending on the type of PID. Observation is …

[HTML][HTML] Cyclosporine before PCI in patients with acute myocardial infarction

…, P Coussement, F Prunier, F Moulin… - … England Journal of …, 2015 - Mass Medical Soc
Background Experimental and clinical evidence suggests that cyclosporine may attenuate
reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine …

Fluoroquinolones in paediatrics: a risk for the patient or for the community?

D Gendrel, M Chalumeau, F Moulin… - The Lancet infectious …, 2003 - thelancet.com
Fluoroquinolones are an important group of antibiotics widely used in adult patients
because of their excellent tissue penetration and their bactericidal activity. They are not …

Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal …

DC Dorman, FJM Moulin, BE McManus… - Toxicological …, 2002 - academic.oup.com
Hydrogen sulfide (H2S) is an important brain, lung, and nose toxicant. Inhibition of
cytochrome oxidase is the primary biochemical effect associated with lethal H2S exposure …

[HTML][HTML] Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children

…, PL Léger, G Geslain, N Semaan, F Moulin… - Annals of intensive …, 2020 - Springer
Background A recent increase in children admitted with hypotensive shock and fever in the
context of the COVID-19 outbreak requires an urgent characterization and assessment of the …

Severe and fatal forms of COVID-19 in children

…, P Frange, G Chéron, J Fourgeaud, F Moulin… - Archives de …, 2020 - Elsevier
Objectives The aim of this study was to describe severe forms of novel coronavirus disease
2019 in children, including patient characteristics, clinical, laboratory, and imaging findings …

Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections

D Gendrel, J Raymond, J Coste, F Moulin… - The Pediatric …, 1999 - journals.lww.com
Background. Procalcitonin (PCT) concentration increases in bacterial infections but remains
low in viral infections and inflammatory diseases. The change is rapid and the molecule is …

Procalcitonin in children admitted to hospital with community acquired pneumonia

F Moulin, J Raymond, M Lorrot, E Marc… - Archives of disease in …, 2001 - adc.bmj.com
AIMS To assess the sensitivity, specificity, and predictive value of procalcitonin (PCT) in
differentiating bacterial and viral causes of pneumonia. METHODS A total of 72 children with …

Measurement of procalcitonin levels in children with bacterial or viral meningitis

…, J Raymond, M Assicot, F Moulin… - Clinical infectious …, 1997 - academic.oup.com
We measured the plasma procalcitonin levels in 59 children who were admitted to the
hospital because of bacterial or viral meningitis. Eighteen children with acute bacterial …